Hecker, Julia
Letizia, Marilena
Loescher, Britt-Sabina
Siegmund, Britta
Weidinger, Carl http://orcid.org/0000-0002-9948-0088
Funding for this research was provided by:
deutsche forschungsgemeinschaft (We 5303/3-1, Si 749/10-1, CRC-TRR241, CRC-TRR 241, CRC 1449, CRC 1340)
clinician scientist program of the berlin institute of health
fritz thyssen stiftung
Charité - Universitätsmedizin Berlin
Article History
Received: 31 July 2021
Accepted: 11 January 2022
First Online: 2 March 2022
Declarations
:
: Informed consent for publication of clinical details and results acquired during diagnosis (including in vitro experiments, mass cytometry, and genetic analysis) was obtained from the patient.
: Obtained.
: BS has served as consultant for Abbvie, Arena, BMS, Boehringer, Celgene, Falk, Janssen, Lilly, Pfizer, Prometheus, and Takeda and received speaker’s fees from Abbvie, CED Service GmbH, Falk, Ferring, Janssen, Novartis, Pfizer, and Takeda (served as a representative of the Charité). The other authors declare no competing interests.